Skip to main navigation Skip to search Skip to main content

A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy

  • Samuel G. Awuah
  • , Yao Rong Zheng
  • , Peter M. Bruno
  • , Michael T. Hemann
  • , Stephen J. Lippard

Research output: Contribution to journalArticlepeer-review

161 Scopus citations

Fingerprint

Dive into the research topics of 'A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology